«Molecule's structure
reveals new therapeutic opportunities for rare diabetes.»
Not exact matches
This pre-clinical study from Professor Mazzone and his colleagues
reveals a
new molecular axis that may offer interesting
therapeutic opportunities for the treatment of pancreatic cancer, breast cancer and lung cancer, among others.
A comprehensive DNA sequencing of pancreatic cancer cases
revealed not only a plethora of damaged genes, but potential diagnostic biomarkers that could help identify those with longer or shorter survival, and provide
opportunity for
new therapeutic interventions.
With the reference cell census data in hand, the research team is excited to conduct additional studies, including ones involving models or human patients with gastrointestinal conditions — Crohn's disease, ulcerative colitis, gastrointestinal cancers, forms of food allergy, etc. — aimed at identifying changes in gene expression and epithelial structure and function that could
reveal new insights and
opportunities for
therapeutic development.